Could fructosamine and glycated albumin testing soon be as common as A1C?…
Read More »Yearly Archives: 2014
Type 2 Diabetes Risk: To Eat Or Not To Eat Meat?
Vegetarian diet may lessen risk of type 2 diabetes….
Read More »The “Obesity Paradox” in Type 2 Diabetes
Increased mortality from cardiovascular outcomes found in overweight patients but….
Read More »Can Secondhand Smoke Increase Diabetes Risk?
The relationship between secondhand smoke exposure and type 2 diabetes….
Read More »How Do Estrone Levels Affect Men and Their Risk for Diabetes?
The relationship of estradiol and estrone to diabetes in men is examined….
Read More »Editor’s Note, DCMS #172: ‘Sedentarism’
Each year there is a contest to find out which new word added to the dictionary is the most popular. Many of you know that the winner this year was ‘selfie’, a self-taken picture which gets posted on Facebook and other social media sites. But when it comes to our …
Read More »Therapy of Type 2 Diabetes Mellitus, Update, Part 8
This week’s Homerun Slides from Dr. Stanley Schwartz cover topics including Non-insulin Therapies and the Recommended Goals for the ABC’s of Diabetes Care (A1c, BP, and Cholesterol)….
Read More »ADA/JDRF Type 1 Diabetes Sourcebook, Excerpt #19: Physical Activity, Part 1
Sheri R. Colberg, PhD, and Michael C. Riddell, PhD Physical Activity: Regulation of Glucose Metabolism, Clinical Management Strategies, and Weight Control Introduction Engaging in regular physical activity is an effective measure to protect against a number of health risks across all ages. Physical activity is known to reduce the risk …
Read More »Editor’s Note, SGLT2 Inhibitors Special Editions, January 2014
I was talking to a physician recently when the topic of SGLT2 inhibitors came up. He spoke about his experience with the drugs and how he felt that a lot of physicians had a negative feeling about the drug because of the chance of UTI’s. He felt that this is …
Read More »History of the SGLT2 Inhibitor Drug Class
Phuong Nguyen, PharmD Candidate, LECOM College of Pharmacy Remarkable as it might sound, the SGLT2 inhibitor drug class arguably dates back 178 years. In 1835, French chemists first isolated a substance known as phlorizin from the bark of apple trees, and in 1886, German physician and early diabetes pioneer Joseph von …
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.